Table 18.
Cardiovascular agents by type
| N (%) | |
|---|---|
| α2 Agonists | 147 (26.3) |
| Clonidine | 120 (21.4) |
| Guanfacine | 26 (4.6) |
| Xylazine | 1 (0.2) |
| Beta blockers | 136 (24.3) |
| Metoprolol | 72 (12.9) |
| Propranolol | 32 (5.7) |
| Atenolol | 15 (2.7) |
| Carvedilol | 13 (2.3) |
| Miscellaneousa | 4 (0.7) |
| Calcium channel blockers | 86 (15.4) |
| Amlodipine | 45 (8.0) |
| Diltiazem | 20 (3.6) |
| Verapamil | 15 (2.7) |
| Miscellaneousb | 6 (1.1) |
| Other antihypertensives and vasodilators | 55 (9.8) |
| Prazosin | 28 (5.0) |
| Antihypertensive unspecified | 11 (2.0) |
| Isosorbide | 6 (1.1) |
| Hydralazine | 5 (0.9) |
| Miscellaneousc | 5 (0.9) |
| ACEI/ARB | 51 (9.1) |
| Lisinopril | 35 (6.2) |
| Losartan | 10 (1.8) |
| Miscellaneousd | 6 (1.1) |
| Antidysrhythmics and other cardiovascular agents | 26 (4.6) |
| Cardiovascular agent unspecified | 11 (2.0) |
| Amiodarone | 5 (0.9) |
| Sotalol | 5 (0.9) |
| Miscellaneouse | 5 (0.9) |
| Cardiac glycosides | 24 (4.3) |
| Digoxin | 23 (4.1) |
| Digitoxin | 1 (0.2) |
| Diuretics | 22 (3.9) |
| Hydrochlorothiazide | 7 (1.2) |
| Furosemide | 6 (1.1) |
| Miscellaneousf | 9 (1.6) |
| Antihyperlipidemic | 13 (2.3) |
| Atorvastatin | 8 (1.4) |
| Miscellaneousg | 5 (0.9) |
| Class total | 560 (100) |
aIncludes bisoprolol, nadolol, and nebivolol
bIncludes lercanidipine and nifedipine
cIncludes nitroglycerin, nitroprusside, pentoxifylline, phentolamine, and tamsulosin
dIncludes enalapril and valsartan
eIncludes dofetilide and flecainide
fIncludes acetazolamide, bumetanide, chlorthalidone, spironolactone, and triamterene
gIncludes lovastatin, rosuvastatin, and simvastatin